Dickinson Dees celebrates closing £36m deal
Dickinson Dees Law Firm is celebrating this morning, after they finalised a £36 million chemicals deal.
Indian firm Vivimed Labs Ltd has purchased Uquifa, the Spanish division of UK-based Yule Catto plc, a company that manufactures Active Pharmaceutical Ingredients for the pharmaceutical industry.
The company has built on its existing success through a continuous acquisition policy, and in 2008 purchased Huddersfield-based dye manufacturer James Robinson.
Phil Ashworth, corporate partner at Dickinson Dees’ Yorkshire office commented: “This has been a fascinating deal to work on. Vivimed Labs is a world-leading organisation with a large portfolio of pharmaceutical products and manufacturing facilities.
“A strategic acquisition such as this with product registrations and specialised facilities, will help Vivimed to serve its export markets and global clients more effectively.”
Dickinson Dees gave a range of comprehensive advice to the firm, including banking, finance, taxation and law, which was especially complex as the two companies were in different countries.
Santosh Varalwar, Chairman and Managing Director of Vivimed Labs said: “Dickinson Dees, led by Philip Ashworth, displayed its strengths in carving out a smooth and efficient deal which will see our India-facing business aligned with Uquifa.
“Strengthening of research and development efforts, opening out new markets and the untapped potential of our combined knowledge of the pharmaceutical sector, together with our consolidated customer base, will mean Uquifa can reinforce its position in the marketplace following this acquisition.”
This was posted in Bdaily's Members' News section by Ruth Mitchell .
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular North East morning email for free.